Viewing nowCiprosel Tablet 250 mg (Ciprofloxacin Hydrochloride Hydrate)
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 200200377 · Notified 2002.07.22 · Insurance code 693900960
Treatment of genitourinary, respiratory, ear, nose and throat, eye, and other infections (intestinal, skin, osteoarticular, etc.)
This medication exhibits effective antibacterial action against a variety of bacteria. It is effective against several types of bacteria including Escherichia coli, Salmonella, and Staphylococcus. It is used to treat various infectious diseases such as respiratory infections, pneumonia, ear, nose and throat infections, bacterial prostatitis, urinary tract infections, gonococcal cervicitis and urethritis, gastrointestinal infections, and is also effective in treating bacterial infections in the skin and soft tissues, bones and joints, gynecological infections, and peritonitis. However, this medication is a fluoroquinolone antibiotic that may be associated with serious adverse reactions, thus it should only be used when no alternative treatment exists for certain mild infections. Therefore, this medication is very useful for treating complex or severe bacterial infections and is used precisely to correspond to the patient's condition to improve symptoms.
○ Adults: The usual dose is 250–500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. Acute infections are usually treated for 5–10 days, and treatment should continue for at least 3 days after symptoms resolve. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30–50 mL/mn: Administer 250–500 mg twice daily 3) 5–29 mL/min: Administer 250–500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250–500 mg once daily after dialysis 5) If only the serum creatinine is known, creatinine clearance may be calculated using the following formula: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the single dose may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. The dose may be adjusted according to symptoms.
This medication may cause serious side effects such as tendonitis or tendon rupture and peripheral neuropathy, therefore it should be discontinued immediately if any abnormal symptoms occur. Patients with myasthenia gravis may experience exacerbation of symptoms if this medication is used, thus it should not be administered. It is advisable for pregnant or breastfeeding women, children and adolescents under 18 years old, and patients with epilepsy to avoid using this medication. Caution is required when this medication is used in elderly patients or those with impaired kidney function and patients with a history of seizures may require dose adjustments. This medication can increase the risk of seizures, so patients with central nervous system disorders should be particularly cautious. Photosensitivity reactions may occur, thus strong sunlight or UV exposure should be avoided, and usage should be discontinued if skin abnormalities arise. Diabetic patients who require blood sugar control should closely monitor changes in blood sugar, and immediate treatment should be provided if hypoglycemic symptoms occur. There may be interactions with various medications, so anyone taking other medications should consult a professional. During the use of this medication, symptoms such as visual disturbances, muscle pain, or difficulty breathing should be reported to healthcare professionals immediately. In the case of overdose, kidney function should be monitored closely and appropriate emergency measures should be taken if necessary. Store this medication in a place out of reach of children, avoiding direct sunlight and UV exposure.
Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, hematocrit decrease, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR, inappropriate secretion of antidiuretic hormone syndrome, allergic reactions, allergic edema, angioedema, anaphylactic reaction, anaphylactoid shock, serum sickness-like reaction, loss of appetite, decreased food intake, increased alkaline phosphatase in the blood, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory loss, loss of taste, tremors, convulsions, dizziness, mental confusion, seizures, drowsiness, migraine, coordination difficulties, olfactory disorders, hyposmia, sensory hypersensitivity, increased intracranial pressure, clumsiness, polyneuropathy, visual disturbances, chromatopsia, diplopia, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastrointestinal discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, colitis with hematochezia, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and spasms, joint swelling, muscle weakness, partial or complete tendon rupture, renal impairment, increased serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, unexplained pain, discomfort, fever, weakness, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, aortic aneurysm, aortic dissection, valvular regurgitation, valvular insufficiency, shock, hypotension, chest tightness, muscle weakness, rhabdomyolysis, cough, chest X-ray abnormalities, eosinophilia, interstitial pneumonia, visual impairment, retinal detachment
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container that is airtight, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy and prevents degradation.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCiprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291.5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Ciprofloxacin Hydrochloride
Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 582mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea United Pharm, Inc.
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.